Joseph Vittiglio's Insider Trades & SAST Disclosures
Joseph Vittiglio's most recent trade in Bluebird bio Inc was a trade of 238 Common Stock done at an average price of $7.4 . Disclosure was reported to the exchange on Feb. 3, 2025.
Add Superstar Alert
Note
This is a custom search result for pattern Joseph Vittiglio.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Bluebird bio Inc
Board Meeting |
Joseph Vittiglio | Chief Business & Legal Officer | Sale of securities on an exchange or to another person at price $ 7.39 per share. | 03 Feb 2025 | 238 | 4,501 (0%) | 0% | 7.4 | 1,759 | Common Stock |
|
Bluebird bio Inc
Board Meeting |
Joseph Vittiglio | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 50,000 | 94,783 (0%) | 0% | 0 | Common Stock | |
|
Bluebird bio Inc
Board Meeting |
Joseph Vittiglio | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 199,000 | 199,000 | - | - | Stock Option (right to buy) | |
|
Bluebird bio Inc
Board Meeting |
Joseph Vittiglio | Chief Business & Legal Officer | Sale of securities on an exchange or to another person at price $ 0.90 per share. | 05 Feb 2024 | 5,217 | 44,783 (0%) | 0% | 0.9 | 4,708 | Common Stock |
|
Finch Therapeutics Group Inc
Board Meeting |
Joseph Vittiglio | Chief Business & Legal Officer | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 21 Oct 2022 | 3,636 | 31,364 | - | 1.4 | 5,054 | Common Stock |
|
Finch Therapeutics Group Inc
Board Meeting |
Joseph Vittiglio | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 35,000 | 35,000 | - | 0 | Common Stock | |
|
Finch Therapeutics Group Inc
Board Meeting |
Joseph Vittiglio | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
|
Finch Therapeutics Group Inc
Board Meeting |
Joseph Vittiglio | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
|
Finch Therapeutics Group Inc
Board Meeting |
Joseph Vittiglio | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2021 | 60,578 | 60,578 | - | - | Employee Stock Option (right to buy) | |
|
Finch Therapeutics Group Inc
Board Meeting |
Joseph Vittiglio | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2021 | 34,616 | 34,616 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges